Connect with us

Health

Chemotherapy for rare cancer fine-tuned with organoids – EurekAlert

A patient-specific tumor organoid model developed at Wake Forest is being used to identify the most effective chemotherapy protocol to treat appendix and colon tumors, a personalized medicine approach that is showing promise.

Published

on

post featured image

WINSTON-SALEM, NC – Aug. 10, 2020, – A patient-specific tumor organoid model is being used to identify the most effective chemotherapy protocol to treat appendix and colon tumors, a personalized medicine approach that is showing promise. The organoids were created by researchers at the Wake Forest Organoid Research Center (WFORCE), a joint effort by the Wake Forest Institute for Regenerative Medicine (WFIRM) and the Wake Forest Comprehensive Cancer Center.
Treatment for advanced stages of colon…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending